An interventional study of Time of exercise and No exercise in Metabolic Regulation, sponsored by University of Bath. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-11.
Sponsored by University of Bath · Not applicable, Interventional, and Basic science
Human Physiology is coordinated by a circadian timing system that synchronises daily cycles of light-dark, wake- sleep, activity-rest and feeding-fasting. The alignment of these behavioural patterns with underlying biological rhythms is closely linked to physiological function, with misalignment linked to chronic metabolic diseases.
The vast majority of evidence about rhythms in metabolism comes from studies of rodents, which is remarkable given that rodents differ fundamentally from humans in both behaviour and metabolic regulation. Moreover, almost no research in any species has examined the effects of muscle contractile activity on 24-h rhythms in metabolism. Skeletal muscle is a key site of metabolic regulation and contractile activity is a powerful stimulus to increase metabolism. The researchers have established a novel protocol for serial muscle sampling throughout 24 hours and pilot work completed in preparation for this grant revealed diurnal transcriptomic and lipidomic rhythms in human skeletal muscle. Further development of that protocol has used enteral feeding via a tube which delivers nutrient directly to the stomach to enable constant nutrient delivery (including during sleep), with preliminary data indicating that underlying rhythms in metabolism are responsive to nutrient availability patterns.
The researchers will now capitalise on those findings by incorporating multiple isotope tracers within the protocol, thus finally documenting the nature of rhythmic flux in carbohydrate metabolism and protein turnover in human skeletal muscle, and how those rhythms are aligned with timing and patterns of exercise. In summary, participants will stay in the laboratory for 36 hours with 24 hours of constant feeding via nasogastric tube, and muscle and blood sampling. Participants will be allocated to either the early or late exercise group (involving 1 hour of cycling at either 0800 or 2000 h, respectively) or the control group who will rest for the 24 hours.
Once eligibility has been verified, participants will attend the laboratory for preliminary testing which will include a submaximal exercise test on an exercise bike. Participants will then be monitored for one-week ahead of their main laboratory visit and will adhere to pre-trial dietary and lifestyle controls for the final 48 h of the pre-trial week (including records of wake/sleep cycles and weighed-food diaries, along with wearable technologies to continuously monitor physical activity, light exposure and sub-cutaneous interstitial glucose concentrations) and standardised meals will be provided to all participants for the 24 h ahead of laboratory visits.
Participants will arrive in the laboratory at 1900 h (DAY 1) the day before the 24-h monitoring period to consume a standardised evening meal (baked potato, beans, broccoli). A cannula will be fitted to an antecubital vein prior and participants will sleep in the laboratory ready for monitoring to commence upon waking the next morning (DAY 2).
At 0600 h, whilst the participant remains asleep, infusion of labelled protein and glucose will be commenced to achieve steady state before starting the sampling period and to allow measurement of protein and glucose metabolism. Resting metabolic rate (the amount of energy required at rest) will be measured immediately upon waking by collecting expired breath samples. Specifically, expired gases will be collected for 20-30 minutes using the gold-standard Douglas bag technique. This measured value will then be used to individually prescribe the energy requirements to be met via nasogastric feeding. A second cannula will then be fitted and a nasogastric tube will be inserted through the nose into the stomach to commence delivery of a nutritionally balanced meal-replacement solution at 0800 h which will be delivered continuously throughout the 24 hour monitoring period. A muscle sample will be obtained at 0730. Participants in the early exercise group will commence 1 hour of exercise at a moderate intensity with 1-min expired breath samples and blood samples collected every 15 minutes and heart rate monitored throughout to verify the exercise intensity.
Further muscle samples will be obtained at 4-h intervals to allow for 7 time-points ending at the final sample at 0800 h the next morning (DAY 3) and blood sampling will occur hourly. The inactive group will follow the same sampling schedule without the exercise. The late exercise group will adhere to the same series of events as described above but with a 12-h delayed shift in time of day. Upon completion of those final tissue samples, participants will be provided with the same breakfast as they had been provided on DAY 1 as part of their dietary standardisation and they will be issued with the same lunch as was consumed on DAY 1 to take away. All wearable devices other than the continuous glucose monitor will then be removed before the participant leaves the laboratory. Body temperature will also be measured throughout the protocol via ingestible thermometers.
Exclusion Criteria:
Other: No exercise
Other: Time of exercise
Other: Time of exercise
The intervention is 1 hour of exercise at 50% between lactate threshold 1 and 2 either in the morning or the evening at the start of the 24 hour sampling period.
The participants will rest for the full 24 hour sampling period.
Carbohydrate flux
Rates of exogenous glucose appearance, endogenous glucose production, total carbohydrate oxidation, exogenous carbohydrate oxidation and net glycogen degradation in muscle biopsies over 24 hours
Time frame: 24 hours
Skeletal muscle protein synthesis
Plasma amino acid concentrations derived from the L-\[ring-13C\]-phenylalanine infusion over 24 hours.
Time frame: 24 hours
Skeletal muscle protein synthesis
Protein fractional synthetic rates in muscle samples derived from the L-\[ring-13C\]-phenylalanine infusion over 24 hours.
Time frame: 24 hours
Mass spectrometry phosphoproteomics
Mass spectrometry phosphoproteomics from skeletal muscle biopsies over 24 hours.
Time frame: 24 hours
Protein content of proteins involved in insulin signalling, glucose transport and protein synthesis.
The content of proteins involved in insulin signalling, glucose transport and protein synthesis determined by semi-quantitative western blotting in skeletal muscle biopsies over 24 hours.
Time frame: 24 hours.
Skeletal muscle gene expression
Transcriptomic and targeted quantitative real-time PCR TaqMan analyses of skeletal muscle gene expression from muscle biopsies over 24 hours.
Time frame: 24 hours
Intramuscular metabolites
Liquid chromatography-mass spectrometry to quantify circulating and intramuscular metabolites indicative of carbohydrate, lipid and amino acid metabolism in skeletal muscle biopsies over 24 hours.
Time frame: 24 hours
Intramuscular enzymes
Liquid chromatography-mass spectrometry to quantify the activation of intramuscular enzymes involved in the formation of acetyl-CoA in skeletal muscle biopsies over 24 hours.
Time frame: 24 hours
Plasma glucose concentrations
Plasma glucose concentrations over 24 hours.
Time frame: 24 hours
Plasma non-esterified fatty acid concentrations
Plasma non-esterified fatty acid concentrations over 24 hours
Time frame: 24 hours
Plasma glycerol concentrations
Plasma glycerol concentrations over 24 hours
Time frame: 24 hours
Plasma triacylglycerol concentrations
Plasma triacylglycerol concentrations over 24 hours
Time frame: 24 hours
Plasma urea concentrations
Plasma urea concentrations over 24 hours
Time frame: 24 hours
Plasma insulin concentrations
Plasma insulin concentrations over 24 hours
Time frame: 24 hours
Plasma glucagon-like peptide-1 concentrations
Plasma glucagon-like peptide-1 concentrations over 24 hours
Time frame: 24 hours
Plasma insulin-like growth factor 1 concentrations
Plasma insulin-like growth factor 1 concentrations over 24 hours
Time frame: 24 hours
Plasma gastric inhibitory polypeptide concentrations
Plasma gastric inhibitory polypeptide concentrations over 24 hours
Time frame: 24 hours
Plasma peptide YY concentrations
Plasma peptide YY concentrations over 24 hours
Time frame: 24 hours
Plasma cortisol concentrations
Plasma cortisol concentrations over 24 hours
Time frame: 24 hours
Plasma total ghrelin concentrations
Plasma total ghrelin concentrations over 24 hours
Time frame: 24 hours
Plasma leptin concentrations
Plasma leptin concentrations over 24 hours
Time frame: 24 hours
Plasma melatonin concentrations
Plasma melatonin concentrations over 24 hours
Time frame: 24 hours
Skeletal muscle lipid concentrations
Skeletal muscle lipid concentrations using lipidomics of muscle biopsy samples over 24 hours
Time frame: 24 hours
Blood cell counts
Plasma blood cell counts (i.e. leukocytes and subsets, erythrocytes and platelets) over 24 hours.
Time frame: 24 hours
Skeletal muscle autophagic flux
Protein content of proteins involved in skeletal muscle autophagic flux determined by semi-quantitative western blotting in muscle biopsy samples over 24 hours.
Time frame: 24 hours
Polysomnography profile
During 11 hours of sleep during pre-trial monitoring and intervention.
Time frame: 11 hours
Heart rate during exercise
Bpm
Time frame: 60 minutes
Rate of perceived exertion during exercise
Borg scale
Time frame: 60 minutes
Body temperature
Body temperature over 24 hours
Time frame: 24 hours
Blood pressure
Blood pressure over 24 hours, mmHg.
Time frame: 24 hours
Energy expenditure during exercise
Time frame: 60 minutes
Plan to share: Yes
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Bath